News
The FDA accepted a supplemental application for Breyanzi to treat adults with relapsed or refractory marginal zone lymphoma ...
Zacks Investment Research on MSN22h
BMY Stock Trades Near 52-Week Low: Time to Buy or Sell?Share price of Bristol Myers Squibb (BMY) touched a 52-week low of $42.96 on July 31, post its second-quarter earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback